Eyegate Pharmaceuticals Inc Warrants 2015-2020 On Shs
(NASDAQ : EYEGW)

( )
EYEGW PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-2.27%166.220.4%$376.39m
AMRNAmarin Corporation Plc Sponsored ADR
-4.82%14.802.0%$117.16m
JAZZJazz Pharmaceuticals Plc
-0.17%138.252.2%$110.84m
PRGOPerrigo Co. Plc
-1.83%55.356.8%$66.11m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-5.32%112.816.3%$52.73m
MNKMallinckrodt Plc
0.76%18.6721.1%$52.38m
ICLRICON Plc
0.41%130.444.1%$44.93m
UTHRUnited Therapeutics Corporation
-0.46%106.1014.4%$38.70m
ICPTIntercept Pharmaceuticals, Inc.
1.45%106.7418.6%$37.74m
SAGESAGE Therapeutics, Inc.
-2.74%98.559.6%$36.74m
HZNPHorizon Pharma plc
-1.20%19.767.4%$34.83m
CTLTCatalent Inc
-2.95%33.232.4%$31.43m
ENDPEndo International Plc
-2.65%9.198.9%$30.16m
ZGNXZogenix, Inc.
-5.25%37.729.9%$25.34m
MDCOMedicines Company
3.83%18.6921.8%$24.70m

Company Profile

EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.S. FDA. The company was founded in 1998 and is headquartered in Waltham, MA.